Table 1 Clinical characteristics of study population based on preoperative surgical anxiety levels

Age (years)‡

42.28 ± 9.09

42.32 ± 10.50

42.24 ± 7.58

0.962

Gravidity†

3 (0–12)

2 (0–8)

3 (0–12)

0.094

Parity‡

2.18 ± 1.49

1.82 ± 1.55

2.52 ± 1.35

0.012

Educational status, primary school*

107 (93.9%)

51 (91.1%)

56 (96.6%)

0.248

Occupation*

0.866

Unemployed

3 (2.6%)

1 (1.8%)

2 (3.4%)

Housewife

86 (75.4%)

42 (75.0%)

44 (75.9%)

Employed

25 (21.9%)

13 (23.2%)

12 (20.7%)

Economic status*

0.472

Low

76 (66.7%)

39 (69.6%)

37 (63.8%)

Middle

38 (33.3%)

17 (30.4%)

21 (36.2%)

Family relationships*

0.001

Good

89 (78.1%)

34 (60.7%)

55 (94.8%)

Moderate

21 (18.4%)

20 (35.7%)

1 (1.7%)

Poor

4 (3.5%)

2 (3.6%)

2 (3.4%)

Family size‡

4.31 ± 1.56

4.05 ± 1.51

4.55 ± 1.59

0.089

Ethnicity, Turkish*

112 (98.2%)

55 (98.2%)

57 (98.3%)

0.985

Smoking status*

82 (71.9%)

44 (78.6%)

38 (65.5%)

0.128

Exercise habits, irregular*

106 (93.0%)

49 (87.5%)

57 (98.3%)

0.041

Mode of last delivery*

0.003

Vaginal

8 (7.0%)

7 (12.5%)

1 (1.7%)

Cesarean

58 (50.9%)

32 (57.1%)

26 (44.8%)

None

48 (42.1%)

17 (30.4%)

31 (53.4%)

Number of previous

cesarean sections‡

0.92 ± 1.07

0.82 ± 1.11

1.02 ± 1.03

0.326

Previous gynecologic surgery*

27 (23.7%)

15 (26.8%)

12 (20.7%)

0.476

Menopausal status*

0.149

Premenopausal

94 (82.5%)

43 (76.8%)

51 (87.9%)

Perimenopausal

7 (6.1%)

4 (7.1%)

3 (5.2%)

Postmenopausal

13 (11.4%)

9 (16.1%)

4 (6.9%)

Hormonal drug usage*

5 (4.4%)

3 (5.4%)

2 (3.4%)

0.672

Body mass index (kg/m²)‡

27.66 ± 5.42

26.94 ± 5.89

28.39 ± 4.86

0.156

History of dysmenorrhea*

74 (64.9%)

33 (58.9%)

41 (70.7%)

0.235

Weekly analgesic use*

0.007

None

95 (83.3%)

40 (71.4%)

55 (94.8%)

1–2 times

15 (13.2%)

13 (23.2%)

2 (3.4%)

≥3 times

4 (3.5%)

3 (5.4%)

1 (1.7%)

Uterine length (mm)†

95 (13–140)

93 (13–120)

95 (90–140)

0.541

Endometrial thickness (mm)‡

10.67 ± 4.27

9.93 ± 3.58

11.38 ± 4.77

0.066

Endometrial tissue, no abnormality*

80 (70.2%)

40 (71.4%)

40 (69.0%)

0.345

Pelvic wall palpation pain*

44 (38.6%)

27 (48.2%)

17 (29.3%)

0.043

Pelvic pain severity†

3 (1–10)

3 (1–10)

4 (1–9)

0.402

Endometriosis*

2 (1.8%)

2 (3.6%)

0 (0%)

0.145

Adenomyosis*

8 (7.0%)

3 (5.4%)

5 (8.6%)

0.486

Uterine fibroids*

17 (14.9%)

8 (14.3%)

9 (15.5%)

0.809

Endometrial polyp*

59 (51.8%)

22 (39.3%)

37 (63.8%)

0.006

Abnormal uterine bleeding*

43 (37.7%)

18 (32.1%)

25 (43.1%)

0.227

Cesarean scar*

38 (33.3%)

9 (16.1%)

29 (50.0%)

< 0.001

Subclinical hypothyroidism*

14 (12.3%)

6 (10.7%)

8 (13.8%)

0.608

Iron deficiency anemia*

0.037

Mild

74 (64.9%)

34 (60.7%)

40 (69.0%)

Moderate

37 (32.5%)

22 (39.3%)

15 (25.9%)

Severe

3 (2.6%)

0 (0.0%)

3 (5.2%)